Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis

NCT03552211 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT03552211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03552211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Observational
Overall status
Unknown status
Start date
May 30, 2018
Completion date
April 30, 2019
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

progressive multiple sclerosis